Onkos Surgical introduced GenVie™ Magnesium Bone Scaffold with application in complex limb salvage procedures. GenVie is the first 510(k) cleared magnesium-based bone void filler in the orthopedic market and is available via a private label distribution agreement with Bone Solutions.
GenVie injectable, moldable bone void filler combines osteoconductive and high compression strength to support bone repair and regeneration. It is used in surgically-created osseous defects or osseous defects from traumatic injury to the bone, and has a reported healing rate of 80% at 26 weeks in a preclinical model.
GenVie complements Onkos’ personalized surgical planning, 3D printed limb salvage offerings and 3D patient-specific joint sparing tools.
Onkos Surgical introduced GenVie™ Magnesium Bone Scaffold with application in complex limb salvage procedures. GenVie is the first 510(k) cleared magnesium-based bone void filler in the orthopedic market and is available via a private label distribution agreement with Bone Solutions.
Onkos Surgical introduced GenVie™ Magnesium Bone Scaffold with application in complex limb salvage procedures. GenVie is the first 510(k) cleared magnesium-based bone void filler in the orthopedic market and is available via a private label distribution agreement with Bone Solutions.
GenVie injectable, moldable bone void filler combines osteoconductive and high compression strength to support bone repair and regeneration. It is used in surgically-created osseous defects or osseous defects from traumatic injury to the bone, and has a reported healing rate of 80% at 26 weeks in a preclinical model.
GenVie complements Onkos’ personalized surgical planning, 3D printed limb salvage offerings and 3D patient-specific joint sparing tools.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
